Cargando…
Developing a patient-centred tool for pain measurement and evaluation in autosomal dominant polycystic kidney disease
BACKGROUND: Pain affects 60% of the autosomal dominant polycystic kidney disease (ADPKD) population. Despite being an early and debilitating symptom, it is poorly characterized and management is suboptimal. This study aimed to develop an ADPKD-specific pain assessment tool (APAT) to facilitate pain...
Autores principales: | El-Damanawi, Ragada, Lee, Michael, Harris, Tess, Cowley, Laura B, Scholtes, Ingrid, Bond, Simon, Sandford, Richard N, Wilkinson, Ian B, Casteleijn, Niek F, Hogan, Marie C, Karet Frankl, Fiona E, Hiemstra, Thomas F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8573025/ https://www.ncbi.nlm.nih.gov/pubmed/34754429 http://dx.doi.org/10.1093/ckj/sfaa259 |
Ejemplares similares
-
Patient Survey of current water Intake practices in autosomal dominant Polycystic kidney disease: the SIPs survey
por: El-Damanawi, Ragada, et al.
Publicado: (2017) -
Randomised controlled trial of high versus ad libitum water intake in patients with autosomal dominant polycystic kidney disease: rationale and design of the DRINK feasibility trial
por: El-Damanawi, Ragada, et al.
Publicado: (2018) -
High water vs. ad libitum water intake for autosomal dominant polycystic kidney disease: a randomized controlled feasibility trial
por: El-Damanawi, R, et al.
Publicado: (2020) -
High water vs. ad libitum water intake for autosomal dominant polycystic kidney disease: a randomized controlled feasibility trial
por: El-Damanawi, R, et al.
Publicado: (2020) -
Somatostatin in renal physiology and autosomal dominant polycystic kidney disease
por: Messchendorp, A Lianne, et al.
Publicado: (2019)